Helicobacter pylori (H. pylori) infection is one of the most common bacterial infections,
affecting almost half of the world's population. It is associated with peptic ulcer disease …

Helicobacter pylori (H. Pylori) infection is currently recognized as the major cause of chronic
active gastritis, peptic ulcer disease and mucosa associated lymphoid tissue (MALT) …

Background The prevalence of Helicobacter pylori (H pylori) in Turkey is high and
eradication rates are low. As a result, alternative treatment strategies are required …

Background: The PREVALENCE of HELICOBACTER PYLORI has declined rapidly in Asia.
This has been shown in both seroprevalence-based and endoscopy-based studies. The …

Several consensus guidelines have been formulated to aid the medical practitioner for
therapy of Helicobacter pylori infection. While triple therapy with a proton pump inhibitor …

Helicobacter pylori has been implicated in the formation of chronic gastritis, peptic ulcer
disease, mucosa-associated lymphoid tissue lymphoma and gastric cancer. Eradication of …

This article assesses the potential role of Helicobacter pylori eradication through antibiotic
therapy in the management of duodenal ulcer, stomach ulcer, stomach cancer, mucosa …

According to the TURHEP study, the prevalence of Helicobacter pylori in Turkey is 82.5%.
After FDA approval in 1995, many countries have used standard triple therapy (proton pump …

Abstract Approximately 50%(over 3 billion) of the world populations are known to be infected
with Helicobacter pylori, mainly in the developing countries. Among those, hundreds of …

Helicobacter pylori is a common bacterial infectious disease whose manifestations
predominately affect the gastrointestinal tract. India is the prototypical developing country as …